Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.

导出 LinkOut

翻译打印收藏纠错

作者： Maarten J,Postma ^[1] ; Annoesjka,Novak ; Huib W K F H,Scheijbeler ; Marlene,Gyldmark ; Marianne L L,van Genugten ; Jan C,Wilschut

作者单位： Graduate Schools SHARE and GUIDE, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands. m.j.postma@rug.nl ^[1]

主题词老年人(Aged);抗病毒药(Antiviral Agents);慢性病(Chronic Disease);患病代价(Cost of Illness);费用效益分析(Cost-Benefit Analysis);女(雌)性(Female);人类(Humans);流感, 人(Influenza, Human);男(雄)性(Male);模型, 经济学(Models, Economic);荷兰(Netherlands);奥司他韦(Oseltamivir);危险(Risk)

DOI 10.2165/00019053-200725060-00005

PMID 17523754

发布时间 2020-05-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览21

PharmacoEconomics

2007年25卷6期

497-509页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.

PharmacoEconomics

相似文献

PharmacoEconomics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.

PharmacoEconomics

相似文献

PharmacoEconomics

相关期刊

检索历史清除